Replay available

Beta Bionics, Inc. (BBNX) Q4 2025 Earnings Call

Beta Bionics, Inc. (NASDAQ: BBNX) Q4 2025 earnings conference call, held 2026-02-17. Replay captured from the company's public earnings webcast.

Tue, February 17, 2026 at 4:30 PMendedReplay
Beta Bionics, Inc. (BBNX) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Blake Bieber

Head of Investor Relations

Sean Saint

Chief Executive Officer

Stephen Feider

Chief Financial Officer

Replay transcript excerpt

good day and thank you for standing by welcome to the beta bionics inc q4 and full year 2025 earnings conference call and webcast at this time all participants are in a listen-only mode please be advised that today's conference is being recorded after the speaker's presentation there will be a question and answer session to ask a question please press star 1 1 on your telephone and wait for your name to be announced to withdraw your question please press star 1 1 again I would now like to hand the conference over to your speaker today, Blake Bieber, Head of Investor Relations. Good afternoon, and thank you for tuning in to Beta Bionic's fourth quarter and full year 2025 earnings call. Joining me for today's call are Chief Executive Officer Sean Saint and Chief Financial Officer Stephen Feider. Both the replay of this call and the press release discussing our fourth quarter and full year 2025 results will be available on the Investor Relations section of our website. The replay will be available for approximately one year following the conclusion of this call. Information recorded on this call speaks only as of today, February 17, 2026. Therefore, if you are listening to any replay, time sensitive information may no longer be accurate. Also on our website is our supplemental fourth quarter 2025 earnings presentation and updated corporate presentation. We encourage you to refer to those documents for a summary of key metrics and business updates. Before we begin, we would like to remind you that today's discussion will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect management's expectations about future events, our product pipeline, development timelines, financial performance, and...

More from Beta Bionics, Inc.